Publication Name	World Journal of Clinical Cases
Manuscript ID	87109
Country	Taiwan

Received	2023-07-27 03:32
Peer-Review Started	2023-07-27 03:36
To Make the First Decision
Return for Revision	2023-09-26 09:34
Revised	2023-09-26 15:03
Second Decision	2023-10-07 02:49
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2023-10-08 03:58
Articles in Press	2023-10-08 03:58
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2023-10-13 02:14
Publish the Manuscript Online	2023-10-25 08:49

ISSN	2307-8960 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Ophthalmology
Manuscript Type	Meta-Analysis
Article Title	Efficacy and safety of anti-vascular endothelial growth factor agents on corneal neovascularization: A meta-analysis
Manuscript Source	Unsolicited Manuscript
All Author List	Shih-Chung Lai, El-Wui Loh, Du-I Chiou and Chien-Tai Hong
ORCID	Author(s) ORCID Number Chien-Tai Hong http://orcid.org/0000-0002-7448-1041
Funding Agency and Grant Number
Corresponding Author	Chien-Tai Hong, MD, PhD, Associate Professor, Department of Neurology, Taipei Medical University-Shuang Ho Hospital, Taipei 110, Taiwan. ct.hong@tmu.edu.tw
Key Words	Efficacy; Safety; Anti-vascular endothelial growth factor agents; Corneal neovascularization; Bevacizumab
Core Tip	Vascular endothelial growth factor (VEGF) inhibitor is one of the pharmacological options for treating corneal neovascularization (CoNV) - the second major cause of blindness. The present study conducted a systematic review and meta-analysis support the use of Bevacizumab in the treatment of CoNV. The results of our study supports that anti-VEGF agents are effective in reducing CoNV, best-corrected visual acuity, and graft rejection/failure rate. In addition, our study found evidence supporting the improvement of visual acuity which was not significant in the previous systematic review and meta-analysis.
Publish Date	2023-10-25 08:49
Citation	Lai SC, Loh EW, Chiou DI, Hong CT. Efficacy and safety of anti-vascular endothelial growth factor agents on corneal neovascularization: A meta-analysis. World J Clin Cases 2023; 11(30): 7337-7349
URL	https://www.wjgnet.com/2307-8960/full/v11/i30/7337.htm
DOI	https://dx.doi.org/10.12998/wjcc.v11.i30.7337

Full Article (PDF)	WJCC-11-7337-with-cover.pdf
Full Article (Word)	WJCC-11-7337.docx
PRISMA 2009 Checklist	87109-PRISMA 2009 Checklist.pdf
Manuscript File	87109_Auto_Edited-LJH-JLW.docx
Answering Reviewers	87109-Answering reviewers.pdf
Audio Core Tip	87109-Audio core tip.mp3
Biostatistics Review Certificate	87109-Biostatistics statement.pdf
Conflict-of-Interest Disclosure Form	87109-Conflict-of-interest statement.pdf
Copyright License Agreement	87109-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	87109-Language certificate.pdf
Peer-review Report	87109-Peer-review(s).pdf
Scientific Misconduct Check	87109-Bing-Liu JH-2.png
Scientific Misconduct Check	87109-CrossCheck.png
Scientific Editor Work List	87109-Scientific editor work list.pdf
CrossCheck Report	87109-CrossCheck report.pdf